Compounds > daunorubicin
Page last updated: 2024-08-23

daunorubicin and curcumin

daunorubicin has been researched along with curcumin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Ampasavate, C; Phattanawasin, P; Piyapolrungroj, N; Sotanaphun, U1
Huang, RW; Huang, SS; Liu, Q; Long, ZJ; Rao, J; Wu, X; Xu, DR; Zheng, FM; Zhou, WH1
Jamil, K; Jayaraman, A1
Ebert, B; Hintzpeter, J; Hornung, J; Martin, HJ; Maser, E1
Afrin, R; Arumugam, S; Giridharan, VV; Hara, M; Harima, M; Karuppagounder, V; Miyashita, S; Nakamura, M; Sreedhar, R; Suzuki, K; Thandavarayan, RA; Ueno, K; Watanabe, K1

Other Studies

6 other study(ies) available for daunorubicin and curcumin

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Effects of Curcuma spp. on P-glycoprotein function.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2010, Volume: 17, Issue:7

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Cell Line; Curcuma; Curcumin; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance; Fluoresceins; Herb-Drug Interactions; Humans; Plant Extracts; Rhodamines; Swine

2010
Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
    Journal of translational medicine, 2011, May-19, Volume: 9

    Topics: Adolescent; Adult; Aged; Antigens, CD34; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Curcumin; Daunorubicin; Drug Resistance, Neoplasm; Drug Synergism; Female; G1 Phase; Gene Expression Regulation, Leukemic; Humans; Leukemia, Myeloid, Acute; Male; Membrane Potential, Mitochondrial; Middle Aged; Poly(ADP-ribose) Polymerases; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; RNA, Small Interfering; S Phase

2011
Drug targets for cell cycle dysregulators in leukemogenesis: in silico docking studies.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Antineoplastic Agents; Arabinonucleosides; Carcinogenesis; Catalytic Domain; Cell Cycle Checkpoints; Cell Cycle Proteins; Curcumin; Daunorubicin; Doxorubicin; Humans; Hydrogen Bonding; Molecular Docking Simulation; Molecular Targeted Therapy; Precursor Cell Lymphoblastic Leukemia-Lymphoma

2014
Curcumin is a tight-binding inhibitor of the most efficient human daunorubicin reductase--Carbonyl reductase 1.
    Chemico-biological interactions, 2015, Jun-05, Volume: 234

    Topics: Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductases; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Curcumin; Daunorubicin; Humans; NADP; Neoplasms

2015
Curcumin alleviates renal dysfunction and suppresses inflammation by shifting from M1 to M2 macrophage polarization in daunorubicin induced nephrotoxicity in rats.
    Cytokine, 2016, Volume: 84

    Topics: Animals; Blood Urea Nitrogen; Creatinine; Curcumin; Daunorubicin; Down-Regulation; Inflammation; Interleukin-10; Kidney; Kidney Function Tests; Macrophages; Male; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Tetraspanin 30

2016